All Issue

2022 Vol.3, Issue 4 Preview Page

Review article

전립선암의 새로운 핵의학적 검사와 치료: PSMA PET/CT 및 방사성동위원소치료
오 주현1
,
유 이령1*
1가톨릭의대 서울성모병원 / 핵의학과
*Corresponding Author
30 December 2022. pp. 127-131
PDF XML Citation
Abstract
Sorry, not available.
Click the PDF button.
References
1
Hofman MS et al., Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study, The Lancet, 2020 10.1016/S0140-6736(20)30314-732209449
2
Pienta KJ et al., A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY), The Journal of Urology, 2021 10.1097/JU.000000000000169833634707PMC8556578
3
Oliver Sartor MD et al., Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer, The New England Journal of Medicine , 2021 10.1016/j.eururo.2022.08.022
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 3
  • No :4
  • Pages :127-131
Journal Informaiton 비뇨의학 Urology Digest 비뇨의학 Urology Digest
  • open access
  • ccl
Journal Informaiton Journal Informaiton - close